Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
Hereditary and metabolic myelopathies.
Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.
Astrocyte-mediated infantile-onset leukoencephalopathy mouse model.
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
The Importance of Thrombin in Cerebral Injury and Disease.
Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study.
Thalamocortical-auditory network alterations following cuprizone-induced demyelination.
Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis.
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis.
Internet-based treatment for depression in multiple sclerosis: A randomized controlled trial.
Autoimmunity in 2015.
[Therapy of fatigue in multiple sclerosis : A treatment algorithm].
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?
[Rapid improvement in visual function after high-dose oral corticosteroids in patients with inflammatory optic neuropathy].
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time.
Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS).
Investigation of cerebral microbleeds in multiple sclerosis as a potential marker of blood-brain barrier dysfunction.

Pages